Sponsor:
National Cancer Institute (NCI)
Code:
NCT05941520
Conditions
Breast Atypical Hyperplasia
Breast Carcinoma
Breast Ductal Carcinoma In Situ
Breast Lobular Carcinoma In Situ
Eligibility Criteria
Sex: Female
Age: 35+
Healthy Volunteers: Not accepted
Interventions
Acolbifene Hydrochloride
Biospecimen Collection
Mammography
Random Periareolar Fine-Needle Aspiration
Tamoxifen
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations